Cargando…

Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most common cause of dementia, affecting approximately two thirds of the 35 million people worldwide with the condition. Despite this, effective treatments are lacking, and there are no drugs that elicit disease modifying effects to improve outcome. There is an urgent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corbett, Anne, Williams, Gareth, Ballard, Clive
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817602/ https://www.ncbi.nlm.nih.gov/pubmed/24275851 http://dx.doi.org/10.3390/ph6101304

Ejemplares similares

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
por: Ventura, Francesc, et al.
Publicado: (2021)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Turning genome-wide association study findings into opportunities for drug repositioning
por: Lau, Alexandria, et al.
Publicado: (2020)

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients
por: Bayraktar, Abdulahad, et al.
Publicado: (2023)

A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
por: Jarada, Tamer N., et al.
Publicado: (2020)

Mining integrated semantic networks for drug repositioning opportunities
por: Mullen, Joseph, et al.
Publicado: (2016)

Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options
por: Cummings, Jeffrey L., et al.
Publicado: (2019)

Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neurons
por: Williams, Gareth, et al.
Publicado: (2019)

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
por: Galeana-Ascencio, Roberto A., et al.
Publicado: (2023)

Development of Pigmentation-Regulating Agents by Drug Repositioning
por: Jeong, Seo-Mi-Gon, et al.
Publicado: (2021)

Knowledge Mapping of Drug Repositioning’s Theme and Development
por: Lang, Xiaona, et al.
Publicado: (2023)

Learning Opportunities for Drug Repositioning via GWAS and PheWAS Findings
por: Yin, Wen, et al.
Publicado: (2018)

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

Robust Sampling of Defective Pathways in Alzheimer’s Disease. Implications in Drug Repositioning
por: Fernández-Martínez, Juan Luis, et al.
Publicado: (2020)

A Proteotranscriptomic-Based Computational Drug-Repositioning Method for Alzheimer’s Disease
por: Lee, Soo Youn, et al.
Publicado: (2020)

Presenilins as Drug Targets for Alzheimer’s Disease—Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development
por: Duncan, R. Scott, et al.
Publicado: (2018)

Cognitive stimulation therapy: training, maintenance and implementation in clinical trials
por: Khan, Zunera, et al.
Publicado: (2014)

Drug Repositioning for Hand, Foot, and Mouth Disease
por: Yan, Ran, et al.
Publicado: (2022)

Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

Integrative Network-Based Analysis Reveals Gene Networks and Novel Drug Repositioning Candidates for Alzheimer Disease
por: Gerring, Zachary F., et al.
Publicado: (2021)

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
por: Laudisi, Federica, et al.
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
por: Bhatia, Shiveena, et al.
Publicado: (2022)

Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases
por: Williams, Kevin, et al.
Publicado: (2015)

Real-World Use of Symptomatic Treatments in Early Alzheimer’s Disease
por: Garcia, Maria João, et al.
Publicado: (2023)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer’s Disease
por: Chyr, Jacqueline, et al.
Publicado: (2022)

The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
por: Won, Jung-Hyun, et al.
Publicado: (2020)

Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2020)

Repositioning of drugs for Parkinson’s disease and pharmaceutical nanotechnology tools for their optimization
por: Hernández-Parra, Héctor, et al.
Publicado: (2022)

Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?
por: Munafò, Antonio, et al.
Publicado: (2020)

Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseases
por: Martin, Paul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_secgi640ofd87apnjvi4lbu5el